Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Trastuzumab Monoclonal Antibody market was valued at US$ 4642.6 million in 2022 and is projected to reach US$ 6357.7 million by 2029, at a CAGR of 4.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Brand Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Trastuzumab Monoclonal Antibody include Roche, Amgen, Pfizer, Organon, Teva and Viatris, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer.
This report aims to provide a comprehensive presentation of the global market for Trastuzumab Monoclonal Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Trastuzumab Monoclonal Antibody. This report contains market size and forecasts of Trastuzumab Monoclonal Antibody in global, including the following market information:
Global Trastuzumab Monoclonal Antibody Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Trastuzumab Monoclonal Antibody Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Trastuzumab Monoclonal Antibody companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Trastuzumab Monoclonal Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Trastuzumab Monoclonal Antibody Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Trastuzumab Monoclonal Antibody Market Segment Percentages, by Type, 2022 (%)
Brand
Biosimilar
Global Trastuzumab Monoclonal Antibody Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Trastuzumab Monoclonal Antibody Market Segment Percentages, by Application, 2022 (%)
Breast Cancer
Stomach Cancer
Global Trastuzumab Monoclonal Antibody Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Trastuzumab Monoclonal Antibody Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Trastuzumab Monoclonal Antibody revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Trastuzumab Monoclonal Antibody revenues share in global market, 2022 (%)
Key companies Trastuzumab Monoclonal Antibody sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Trastuzumab Monoclonal Antibody sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Amgen
Pfizer
Organon
Teva
Viatris
Outline of Major Chapters:
Chapter 1: Introduces the definition of Trastuzumab Monoclonal Antibody, market overview.
Chapter 2: Global Trastuzumab Monoclonal Antibody market size in revenue and volume.
Chapter 3: Detailed analysis of Trastuzumab Monoclonal Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Trastuzumab Monoclonal Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Trastuzumab Monoclonal Antibody capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Trastuzumab Monoclonal Antibody Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Trastuzumab Monoclonal Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Trastuzumab Monoclonal Antibody Overall Market Size
2.1 Global Trastuzumab Monoclonal Antibody Market Size: 2022 VS 2029
2.2 Global Trastuzumab Monoclonal Antibody Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Trastuzumab Monoclonal Antibody Sales: 2018-2029
3 Company Landscape
3.1 Top Trastuzumab Monoclonal Antibody Players in Global Market
3.2 Top Global Trastuzumab Monoclonal Antibody Companies Ranked by Revenue
3.3 Global Trastuzumab Monoclonal Antibody Revenue by Companies
3.4 Global Trastuzumab Monoclonal Antibody Sales by Companies
3.5 Global Trastuzumab Monoclonal Antibody Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Trastuzumab Monoclonal Antibody Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Trastuzumab Monoclonal Antibody Product Type
3.8 Tier 1, Tier 2 and Tier 3 Trastuzumab Monoclonal Antibody Players in Global Market
3.8.1 List of Global Tier 1 Trastuzumab Monoclonal Antibody Companies
3.8.2 List of Global Tier 2 and Tier 3 Trastuzumab Monoclonal Antibody Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Trastuzumab Monoclonal Antibody Market Size Markets, 2022 & 2029
4.1.2 Brand
4.1.3 Biosimilar
4.2 By Type - Global Trastuzumab Monoclonal Antibody Revenue & Forecasts
4.2.1 By Type - Global Trastuzumab Monoclonal Antibody Revenue, 2018-2023
4.2.2 By Type - Global Trastuzumab Monoclonal Antibody Revenue, 2024-2029
4.2.3 By Type - Global Trastuzumab Monoclonal Antibody Revenue Market Share, 2018-2029
4.3 By Type - Global Trastuzumab Monoclonal Antibody Sales & Forecasts
4.3.1 By Type - Global Trastuzumab Monoclonal Antibody Sales, 2018-2023
4.3.2 By Type - Global Trastuzumab Monoclonal Antibody Sales, 2024-2029
4.3.3 By Type - Global Trastuzumab Monoclonal Antibody Sales Market Share, 2018-2029
4.4 By Type - Global Trastuzumab Monoclonal Antibody Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Trastuzumab Monoclonal Antibody Market Size, 2022 & 2029
5.1.2 Breast Cancer
5.1.3 Stomach Cancer
5.2 By Application - Global Trastuzumab Monoclonal Antibody Revenue & Forecasts
5.2.1 By Application - Global Trastuzumab Monoclonal Antibody Revenue, 2018-2023
5.2.2 By Application - Global Trastuzumab Monoclonal Antibody Revenue, 2024-2029
5.2.3 By Application - Global Trastuzumab Monoclonal Antibody Revenue Market Share, 2018-2029
5.3 By Application - Global Trastuzumab Monoclonal Antibody Sales & Forecasts
5.3.1 By Application - Global Trastuzumab Monoclonal Antibody Sales, 2018-2023
5.3.2 By Application - Global Trastuzumab Monoclonal Antibody Sales, 2024-2029
5.3.3 By Application - Global Trastuzumab Monoclonal Antibody Sales Market Share, 2018-2029
5.4 By Application - Global Trastuzumab Monoclonal Antibody Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Trastuzumab Monoclonal Antibody Market Size, 2022 & 2029
6.2 By Region - Global Trastuzumab Monoclonal Antibody Revenue & Forecasts
6.2.1 By Region - Global Trastuzumab Monoclonal Antibody Revenue, 2018-2023
6.2.2 By Region - Global Trastuzumab Monoclonal Antibody Revenue, 2024-2029
6.2.3 By Region - Global Trastuzumab Monoclonal Antibody Revenue Market Share, 2018-2029
6.3 By Region - Global Trastuzumab Monoclonal Antibody Sales & Forecasts
6.3.1 By Region - Global Trastuzumab Monoclonal Antibody Sales, 2018-2023
6.3.2 By Region - Global Trastuzumab Monoclonal Antibody Sales, 2024-2029
6.3.3 By Region - Global Trastuzumab Monoclonal Antibody Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Trastuzumab Monoclonal Antibody Revenue, 2018-2029
6.4.2 By Country - North America Trastuzumab Monoclonal Antibody Sales, 2018-2029
6.4.3 US Trastuzumab Monoclonal Antibody Market Size, 2018-2029
6.4.4 Canada Trastuzumab Monoclonal Antibody Market Size, 2018-2029
6.4.5 Mexico Trastuzumab Monoclonal Antibody Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Trastuzumab Monoclonal Antibody Revenue, 2018-2029
6.5.2 By Country - Europe Trastuzumab Monoclonal Antibody Sales, 2018-2029
6.5.3 Germany Trastuzumab Monoclonal Antibody Market Size, 2018-2029
6.5.4 France Trastuzumab Monoclonal Antibody Market Size, 2018-2029
6.5.5 U.K. Trastuzumab Monoclonal Antibody Market Size, 2018-2029
6.5.6 Italy Trastuzumab Monoclonal Antibody Market Size, 2018-2029
6.5.7 Russia Trastuzumab Monoclonal Antibody Market Size, 2018-2029
6.5.8 Nordic Countries Trastuzumab Monoclonal Antibody Market Size, 2018-2029
6.5.9 Benelux Trastuzumab Monoclonal Antibody Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Trastuzumab Monoclonal Antibody Revenue, 2018-2029
6.6.2 By Region - Asia Trastuzumab Monoclonal Antibody Sales, 2018-2029
6.6.3 China Trastuzumab Monoclonal Antibody Market Size, 2018-2029
6.6.4 Japan Trastuzumab Monoclonal Antibody Market Size, 2018-2029
6.6.5 South Korea Trastuzumab Monoclonal Antibody Market Size, 2018-2029
6.6.6 Southeast Asia Trastuzumab Monoclonal Antibody Market Size, 2018-2029
6.6.7 India Trastuzumab Monoclonal Antibody Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Trastuzumab Monoclonal Antibody Revenue, 2018-2029
6.7.2 By Country - South America Trastuzumab Monoclonal Antibody Sales, 2018-2029
6.7.3 Brazil Trastuzumab Monoclonal Antibody Market Size, 2018-2029
6.7.4 Argentina Trastuzumab Monoclonal Antibody Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Trastuzumab Monoclonal Antibody Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Trastuzumab Monoclonal Antibody Sales, 2018-2029
6.8.3 Turkey Trastuzumab Monoclonal Antibody Market Size, 2018-2029
6.8.4 Israel Trastuzumab Monoclonal Antibody Market Size, 2018-2029
6.8.5 Saudi Arabia Trastuzumab Monoclonal Antibody Market Size, 2018-2029
6.8.6 UAE Trastuzumab Monoclonal Antibody Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Trastuzumab Monoclonal Antibody Major Product Offerings
7.1.4 Roche Trastuzumab Monoclonal Antibody Sales and Revenue in Global (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Trastuzumab Monoclonal Antibody Major Product Offerings
7.2.4 Amgen Trastuzumab Monoclonal Antibody Sales and Revenue in Global (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Trastuzumab Monoclonal Antibody Major Product Offerings
7.3.4 Pfizer Trastuzumab Monoclonal Antibody Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Organon
7.4.1 Organon Company Summary
7.4.2 Organon Business Overview
7.4.3 Organon Trastuzumab Monoclonal Antibody Major Product Offerings
7.4.4 Organon Trastuzumab Monoclonal Antibody Sales and Revenue in Global (2018-2023)
7.4.5 Organon Key News & Latest Developments
7.5 Teva
7.5.1 Teva Company Summary
7.5.2 Teva Business Overview
7.5.3 Teva Trastuzumab Monoclonal Antibody Major Product Offerings
7.5.4 Teva Trastuzumab Monoclonal Antibody Sales and Revenue in Global (2018-2023)
7.5.5 Teva Key News & Latest Developments
7.6 Viatris
7.6.1 Viatris Company Summary
7.6.2 Viatris Business Overview
7.6.3 Viatris Trastuzumab Monoclonal Antibody Major Product Offerings
7.6.4 Viatris Trastuzumab Monoclonal Antibody Sales and Revenue in Global (2018-2023)
7.6.5 Viatris Key News & Latest Developments
8 Global Trastuzumab Monoclonal Antibody Production Capacity, Analysis
8.1 Global Trastuzumab Monoclonal Antibody Production Capacity, 2018-2029
8.2 Trastuzumab Monoclonal Antibody Production Capacity of Key Manufacturers in Global Market
8.3 Global Trastuzumab Monoclonal Antibody Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Trastuzumab Monoclonal Antibody Supply Chain Analysis
10.1 Trastuzumab Monoclonal Antibody Industry Value Chain
10.2 Trastuzumab Monoclonal Antibody Upstream Market
10.3 Trastuzumab Monoclonal Antibody Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Trastuzumab Monoclonal Antibody Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
